The Impact of Intraoperative Systemic Lidocaine Infusion on Chronic Postoperative Pain After Video-assisted Thoracic Surgery (VATS)

March 28, 2019 updated by: Yonsei University
Systemic lidocaine infusion may improve the patients' chronic post surgical pain after video-assisted thoracic surgery

Study Overview

Study Type

Interventional

Enrollment (Actual)

168

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, Korea, Republic of, 120-752
        • Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age between 20 and 65 years
  • ASA class 1 and 2
  • Patients who are scheduled for video-assisted thoracic surgery

Exclusion Criteria:

  • Allergy to local anesthetics or contraindication to use of lidocaine
  • Pregnancy
  • Severe cardiovascular disease
  • Renal failure
  • Liver failure
  • Neurologic and psychologic disease
  • Chronic treatment with analgesics or chronic pain patients
  • Previous history of thoracic surgery (open or video-assisted)
  • Patients' refusal

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Group L
Intravenous lidocaine infusion group
In group L, intravenous lidocaine infusion(0.1mg/kg) for 10minutes after induction of anesthesia. After 10 minutes, lidocaine infusion continued at rate of 3mg/kg/hr during operation, and discontinued before move the patients to PACU.
ACTIVE_COMPARATOR: Group C
Intravenous normal saline infusion - control group
In group C, the patients receive same volume of normal saline

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessing pain score after operation
Time Frame: 2 months after operation
Assessing pain score by Short-form McGill pain questionnaire at 2 months after operation
2 months after operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (ACTUAL)

August 22, 2016

Study Completion (ACTUAL)

August 22, 2016

Study Registration Dates

First Submitted

December 4, 2013

First Submitted That Met QC Criteria

December 4, 2013

First Posted (ESTIMATE)

December 10, 2013

Study Record Updates

Last Update Posted (ACTUAL)

April 1, 2019

Last Update Submitted That Met QC Criteria

March 28, 2019

Last Verified

December 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lung Cancer(Primary, Metastatic)

Clinical Trials on Systemic intravenous lidocaine infusion

3
Subscribe